Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Severe Combined Immunodeficiency | 1 | 2021 | 107 | 0.83 | Why? |
| Immunologic Deficiency Syndromes | 3 | 2019 | 368 | 0.82 | Why? |
| Granulomatous Disease, Chronic | 1 | 2018 | 60 | 0.71 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 130 | 0.68 | Why? |
| Granuloma | 1 | 2018 | 88 | 0.67 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.60 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.59 | Why? |
| Pediatric Obesity | 1 | 2020 | 492 | 0.58 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.56 | Why? |
| Muscular Diseases | 1 | 2018 | 392 | 0.49 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.48 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2018 | 760 | 0.46 | Why? |
| Immune System | 1 | 2020 | 1479 | 0.43 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.43 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.30 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.27 | Why? |
| Complement Membrane Attack Complex | 2 | 2020 | 153 | 0.25 | Why? |
| Asthma | 4 | 2021 | 4383 | 0.22 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.21 | Why? |
| Systemic Inflammatory Response Syndrome | 4 | 2021 | 6653 | 0.21 | Why? |
| Gabexate | 1 | 2020 | 88 | 0.21 | Why? |
| Adipokines | 1 | 2020 | 87 | 0.20 | Why? |
| Seizures, Febrile | 1 | 2019 | 59 | 0.19 | Why? |
| Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 1645 | 0.19 | Why? |
| Homeodomain Proteins | 1 | 2019 | 93 | 0.18 | Why? |
| Pyrin Domain | 1 | 2017 | 1 | 0.18 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.18 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.17 | Why? |
| Esters | 1 | 2020 | 300 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.16 | Why? |
| Thrombotic Microangiopathies | 1 | 2020 | 335 | 0.16 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.16 | Why? |
| Rabbits | 1 | 2020 | 1171 | 0.16 | Why? |
| Serine Proteinase Inhibitors | 1 | 2020 | 341 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Skin Diseases, Infectious | 1 | 2017 | 77 | 0.15 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.15 | Why? |
| Anti-Asthmatic Agents | 1 | 2020 | 427 | 0.15 | Why? |
| Adipose Tissue | 1 | 2020 | 612 | 0.15 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.14 | Why? |
| Child Health Services | 1 | 2020 | 520 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.12 | Why? |
| Hospitals, Pediatric | 2 | 2020 | 1792 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Dermatologic Agents | 1 | 2017 | 489 | 0.11 | Why? |
| Child | 13 | 2021 | 70012 | 0.10 | Why? |
| Appointments and Schedules | 1 | 2018 | 1204 | 0.10 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.10 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.10 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.09 | Why? |
| Dermatitis, Atopic | 1 | 2017 | 714 | 0.09 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.08 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2020 | 7220 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.08 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Infant | 4 | 2021 | 30274 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.07 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.07 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.07 | Why? |
| Protein-Tyrosine Kinases | 1 | 2005 | 158 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.07 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 176 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Genome-Wide Association Study | 2 | 2021 | 1648 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Male | 13 | 2021 | 367725 | 0.05 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.05 | Why? |
| Emergency Service, Hospital | 3 | 2020 | 14232 | 0.05 | Why? |
| Leukopenia | 1 | 2021 | 280 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Philadelphia | 1 | 2020 | 454 | 0.05 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.05 | Why? |
| Adenovirus Infections, Human | 1 | 2020 | 145 | 0.05 | Why? |
| Nitrogen Dioxide | 1 | 2020 | 488 | 0.04 | Why? |
| Paramyxoviridae Infections | 1 | 2020 | 364 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.04 | Why? |
| Coronaviridae Infections | 1 | 2020 | 442 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2017 | 303 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.04 | Why? |
| Picornaviridae Infections | 1 | 2020 | 544 | 0.04 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.04 | Why? |
| Genetic Predisposition to Disease | 2 | 2021 | 4027 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.03 | Why? |
| Gene Expression | 1 | 2005 | 3332 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.03 | Why? |
| Ozone | 1 | 2020 | 757 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Flow Cytometry | 1 | 2021 | 2393 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Telephone | 1 | 2020 | 1705 | 0.03 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.03 | Why? |
| Animals | 1 | 2020 | 78931 | 0.03 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Continuity of Patient Care | 1 | 2018 | 1574 | 0.02 | Why? |
| Particulate Matter | 1 | 2020 | 3249 | 0.02 | Why? |
| Videoconferencing | 1 | 2020 | 2081 | 0.02 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.02 | Why? |
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2005 | 2 | 0.02 | Why? |
| Cyclin D3 | 1 | 2005 | 5 | 0.02 | Why? |
| Cyclins | 1 | 2005 | 16 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 2426 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 343 | 0.02 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 243 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Cell Cycle Proteins | 1 | 2005 | 297 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.01 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Gene Expression Profiling | 1 | 2005 | 3788 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Middle Aged | 3 | 2019 | 270681 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Aged | 2 | 2017 | 215776 | 0.00 | Why? |
| Aged, 80 and over | 1 | 2005 | 88759 | 0.00 | Why? |
Henrickson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_